Study of Oxaliplatin and Taxotere in Androgen Independent Prostate Cancer

Trial Profile

Study of Oxaliplatin and Taxotere in Androgen Independent Prostate Cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Apr 2014

At a glance

  • Drugs Docetaxel (Primary) ; Oxaliplatin (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 19 Jan 2012 Additional lead trial investigator (Leonard J Appleman) identified as reported by ClinicalTrials.gov.
    • 19 Jan 2012 Actual patient number (34) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top